MSD Pharmaceuticals' Gardasil 4 vaccine and Serum Institute's Cervavac are quadrivalent vaccines that target four HPV sub-types -- 6, 11, 16 and 18. MSD's Gardasil 9, which is India's first ...

MSD Pharmaceuticals' Gardasil 4 vaccine and Serum Institute's Cervavac are quadrivalent vaccines that target four HPV sub-types -- 6, 11, 16 and 18. MSD's Gardasil 9, which is India's first ...

Currently, prominent vaccines such as Gardasil 4 from MSD Pharmaceuticals and Cervavac from the Serum Institute of India are available. These vaccines cover multiple HPV sub-types, contributing to ...

Three main vaccines are currently available: Gardasil, Cervarix, and Cervavac. Gardasil, a quadrivalent vaccine, protects against HPV types 6, 11, 16, and 18, and costs approximately Rs 9,000 for ...

Gardasil 9, manufactured by Merck, protects against nine strains of the human papillomavirus, an infection transmitted through direct or indirect contact with the genitals of an infected person.

Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ride in China. A post-Covid surge in demand for the cancer-preventing shot quickly deflated last year, to the point the US ...

The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is halting shipments to the world’s second-most populous country.

Quarterly Gardasil sales of $1.55 billion missed Wall Street's estimates of around $1.8 billion, which has been pared back nearly 20% since the issues in China were disclosed last summer.

Pause on Gardasil China sales from Feb to at least mid-2025 Keytruda beats, Gardasil misses Q4 sales estimates Merck pulls Gardasil's long-term sales target Shares tumble 11% in early trading Feb ...

Shares fell more than 10% as Merck paused Gardasil shipments to China, and 2025 sales guidance of $64.1 billion-$65.6 billion implies flat to 2% growth. Why it matters: HPV vaccine Gardasil has ...

Jan 18 (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los ...

The approval makes GARDASIL the first HPV vaccine approved for use in males in China. GARDASIL is now indicated in China to prevent anal cancers caused by HPV Types 16 and 18, genital warts ...